| D08667 | |
| D number | D08667 |
| Classification | Drug |
| Name | Calcium valproate; Valproic acid calcium salt; Convulsofin (TN) |
| Component | - |
| Formula | (C8H15O2)2. Ca |
| Exact mass | 326.177 |
| Mol weight | 326.485 |
| Structural formula |  |
| Sequence | - |
| Sequence type | - |
| Source | - |
| Upper DGroup | Neuropsychiatric agent DG02035 Fatty acid antiepileptics Other DG01575 Calcium channel blocker DG01573 Calcium channel T type blocker Cyp substrate DG01633 CYP3A substrate |
| Remark | ATC code: N03AG01 Chemical group: DG00849 |
| Activity | - |
| Disease | - |
| Comment | Fatty acid derivative Valproic acid is contraindicated in patients with known urea cycle disorders [DS:H00164 H00185 H00186 H00187 H01028 H01032] |
| Target | ABAT [HSA:18] [KO:K13524]; SSADH [HSA:7915] [KO:K00139]; GAD [HSA:2571 2572] [KO:K01580]; CACNA1-T [HSA:8911 8912 8913] [KO:K04856 K04855 K04854] |
| Metabolism | - |
| Interaction | Genomic biomarker: (1) NAGS [HSA:162417], CPS [HSA:1373], ASS [HSA:445], OTC [HSA:5009], ASL [HSA:435], ARG [HSA:383 384], (2) POLG [HSA:5428] |
| Other DBs | CAS: 33433-82-8 PubChem: 96025350 LigandBox: D08667 NIKKAJI: J308.487F |
| KCF data | - |